pmc logo image
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
Christian Dejaco, Werner Klotz, Heike Larcher, Christina Duftner, Michael Schirmer, Manfred Herold
Arthritis Res Ther. 2006; 8(4): R119. Published online 2006 July 19. doi: 10.1186/ar2008
PMCID:
PMC1779400
Abstract Full Text PDF–174K Supplementary Material
 Is Cited by the Following 9 Articles in this Archive:
Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis
Mariusz Puszczewicz, Cezary Iwaszkiewicz
Arch Med Sci. 2011 April; 7(2): 189–194. Published online 2011 May 17. doi: 10.5114/aoms.2011.22067
PMCID:
PMC3258718
Abstract Full Text PDF–75K
Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis
Mariusz Puszczewicz, Cezary Iwaszkiewicz
Arch Med Sci. 2011 April; 7(2): 189–194. Published online 2011 May 17. doi: 10.5114/aoms.2011.22067
PMCID:
PMC3258718
Abstract Full Text PDF–75K
Immediate determination of ACPA and rheumatoid factor - a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay
Franziska Renger, Holger Bang, Eugen Feist, Gert Fredenhagen, Alexander Natusch, Marina Backhaus, Gerd-R Burmester, Karl Egerer
Arthritis Res Ther. 2010; 12(3): R120. Published online 2010 June 22. doi: 10.1186/ar3057
PMCID:
PMC2911914
Abstract Full Text PDF–411K Supplementary Material
B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy
Diego Catalán, Octavio Aravena, Francisca Sabugo, Pamela Wurmann, Lilian Soto, Alexis M Kalergis, Miguel Cuchacovich, Juan C Aguillón
Arthritis Res Ther. 2010; 12(2): R68. Published online 2010 April 15. doi: 10.1186/ar2985
PMCID:
PMC2888223
Abstract Full Text PDF–666K
The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis
Ger JM Pruijn, Allan Wiik, Walther J van Venrooij
Arthritis Res Ther. 2010; 12(1): 203. Published online 2010 February 15. doi: 10.1186/ar2903
PMCID:
PMC2875630
Abstract Full Text PDF–174K
Anti-Citrullinated Peptide Antibody (ACPA) Assays and their Role in the Diagnosis of Rheumatoid Arthritis
Rohit Aggarwal, Katherine Liao, Raj Nair, Sarah Ringold, Karen H. Costenbader
Arthritis Rheum. Author manuscript; available in PMC 2010 November 15.
Published in final edited form as: Arthritis Rheum. 2009 November 15; 61(11): 1472–1483. doi: 10.1002/art.24827
PMCID:
PMC2859449
Abstract Full Text PDF–328K
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
Pascale Nicaise Roland, Sabine Grootenboer Mignot, Alessandra Bruns, Margarita Hurtado, Elisabeth Palazzo, Gilles Hayem, Philippe Dieudé, Olivier Meyer, Sylvie Chollet Martin
Arthritis Res Ther. 2008; 10(6): R142. Published online 2008 December 10. doi: 10.1186/ar2570
PMCID:
PMC2656247
Abstract Full Text PDF–179K
Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
Jennie Ursum, Markus MJ Nielen, Dirkjan van Schaardenburg, Ann R van der Horst, Rob J van de Stadt, Ben AC Dijkmans, Dörte Hamann
Arthritis Res Ther. 2008; 10(1): R12. Published online 2008 January 28. doi: 10.1186/ar2362
PMCID:
PMC2374444
Abstract Full Text PDF–208K
Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis
Walther J. van Venrooij, Albert J. W. Zendman
Clin Rev Allergy Immunol. 2008 February; 34(1): 36–39. Published online 2007 September 18. doi: 10.1007/s12016-007-8029-y
PMCID:
PMC2243253
Abstract Full Text PDF–74K
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk